Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-18
2006-07-18
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S415000, C548S361500, C548S494000
Reexamination Certificate
active
07078425
ABSTRACT:
Disclosed are compounds of the Formula (I) and pharmaceutically acceptable salts and prodrugs thereof, wherein A, B, R1, R2, R3, and R4are as defined in the specification. Such compounds are tyrosine phosphatase inhibitors and useful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed by the invention are formulations comprising the noted compounds, processes for preparing such compounds, a method for treating or preventing Type II Diabetes Mellitus
REFERENCES:
patent: WO 00/53583 (2000-09-01), None
patent: WO 200053583 (2000-09-01), None
Groneberg Robert D.
Mareska David A.
Array Biopharma Inc.
Barker Michael
McDonnell Boehnen & Hulbert & Berghoff LLP
Saeed Kamal A.
LandOfFree
Preparation of phosphatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of phosphatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of phosphatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531772